Now showing items 1-4 of 4
Epidemiology of neurocysticercosis in Brazil
(Revista do Instituto de Medicina Tropical de São Paulo, 1996-05-01) [Artigo]
A revision of literature was done with the objective of tracing an epidemiologic profile of neurocysticercosis (NCC) in Brazil. The prevalence was 0.12-9% in autopsies. The frequency was 0.03-7.5% in clinical series and ...
Evaluation of Paracoccidioides brasiliensis exoantigen in the detection of delayed dermal hypersensitivity in experimental and human paracoccidioidomycosis
(Journal of Medical and Veterinary Mycology, 1996-10-19) [Artigo]
The exoantigen of Paracoccidioides brasiliensis standardized by Camargo et al.  (AgR) was used to evaluate the in vivo and in vitro cell immune response of experimental animals and of patients with paracoccidioidomycosis ...
Paracoccidioides brasiliensis-gp43 used as paracoccidioidin
(Journal of Medical and Veterinary Mycology, 1996-12-01) [Artigo]
A purified glycoprotein of 43 000 daltons from Paracoccidioides brasiliensis (gp43) was tested as paracoccidioidin in delayed-type hypersensitivity (DTH) tests in both experimental animals (guinea pig and mice) and patients ...
Severe forms of neurocysticercosis: Treatment with albeimdazole
(Arquivos de Neuro-Psiquiatria, 1996-03-01) [Artigo]
Study of 22 patients with the severe form of neurocysticercosis treated with albendazole (ABZ) administered in 6 different schedules ranging from 15 to 30 mg/kg/day for 21 to 60 days. Dextrochloropheniramine and ketoprofen ...